Home
LYEL
LYEL News

Latest Lyell Immunopharma Inc. (LYEL) News on January 22, 2025

Lyell to Highlight Vision for its Next-Generation CAR T-Cell Therapy Pipeline at 43rd Annual JP Morgan Healthcare Conference

GlobeNewswire

13 days ago

Lyell to Highlight Vision for its Next-Generation CAR T-Cell Therapy Pipeline at 43rd Annual JP Morgan Healthcare Conference

After Plunging -37.9% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)

Zacks

22 days ago

After Plunging -37.9% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)

After Plunging -31.22% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)

Zacks

23 days ago

After Plunging -31.22% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)

Down -30.89% in 4 Weeks, Here's Why Lyell Immunopharma (LYEL) Looks Ripe for a Turnaround

Zacks

a month ago

Down -30.89% in 4 Weeks, Here's Why Lyell Immunopharma (LYEL) Looks Ripe for a Turnaround

Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting

GlobeNewswire

a month ago

Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting

Lyell Immunopharma (LYEL) Upgraded to Buy: Here's What You Should Know

Zacks

2 months ago

Lyell Immunopharma (LYEL) Upgraded to Buy: Here's What You Should Know

Associated Press Finance

2 months ago

Lyell Immunopharma: Q3 Earnings Snapshot

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024

GlobeNewswire

2 months ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024

Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting

GlobeNewswire

3 months ago

Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting

LiveOne Leads The Pack Of 3 US Penny Stocks

Simply Wall St.

3 months ago

LiveOne Leads The Pack Of 3 US Penny Stocks

Lyell Immunopharma Completes Acquisition of ImmPACT Bio

GlobeNewswire

3 months ago

Lyell Immunopharma Completes Acquisition of ImmPACT Bio

MT Newswires

3 months ago

Lyell Immunopharma Shares Fall After BofA Downgrade

Investing.com

3 months ago

Lyell shares down as BofA double downgrades to Sell

Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline

Pharmaceutical Technology

3 months ago

Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline

Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies

GlobeNewswire

3 months ago

Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies

Lyell, in search of a turnaround, to buy cell therapy startup ImmPact

BioPharma Dive

3 months ago

Lyell, in search of a turnaround, to buy cell therapy startup ImmPact

Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire

4 months ago

Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day

GlobeNewswire

4 months ago

Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day

Lyell Immunopharma Announces Participation in September Investor Conferences

GlobeNewswire

5 months ago

Lyell Immunopharma Announces Participation in September Investor Conferences

Recent uptick might appease Lyell Immunopharma, Inc. (NASDAQ:LYEL) institutional owners after losing 32% over the past year

Simply Wall St.

5 months ago

Recent uptick might appease Lyell Immunopharma, Inc. (NASDAQ:LYEL) institutional owners after losing 32% over the past year

MT Newswires

5 months ago

Caribou Biosciences Names Tina Albertson as Chief Medical Officer

Associated Press Finance

5 months ago

Lyell Immunopharma: Q2 Earnings Snapshot

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024

GlobeNewswire

5 months ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024

Lyell Immunopharma Shares Plunge On One Patient Death In CAR-T Cell Therapy Cancer Trial

Benzinga

7 months ago

Lyell Immunopharma Shares Plunge On One Patient Death In CAR-T Cell Therapy Cancer Trial

Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology

GlobeNewswire

7 months ago

Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology

Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference

GlobeNewswire

8 months ago

Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference

Lyell Immunopharma to Participate in BofA Securities Health Care Conference

GlobeNewswire

8 months ago

Lyell Immunopharma to Participate in BofA Securities Health Care Conference

Lyell Immunopharma First Quarter 2024 Earnings: US$0.24 loss per share (vs US$0.27 loss in 1Q 2023)

Simply Wall St.

9 months ago

Lyell Immunopharma First Quarter 2024 Earnings: US$0.24 loss per share (vs US$0.27 loss in 1Q 2023)

MT Newswires

9 months ago

Lyell Immunopharma Shares Rise After Q1 Net Loss Narrows

Associated Press Finance

9 months ago

Lyell Immunopharma: Q1 Earnings Snapshot

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024

GlobeNewswire

9 months ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024

Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returns

Simply Wall St.

10 months ago

Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returns

Lyell Immunopharma (LYEL) Is Up 28.45% in One Week: What You Should Know

Zacks

a year ago

Lyell Immunopharma (LYEL) Is Up 28.45% in One Week: What You Should Know

Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting

GlobeNewswire

a year ago

Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting

Lyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlights

GuruFocus.com

a year ago

Lyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlights

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023

GlobeNewswire

a year ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023

Lyell Immunopharma Announces Participation in March Investor Conferences

GlobeNewswire

a year ago

Lyell Immunopharma Announces Participation in March Investor Conferences

Pitney Bowes (PBI) Beats Q4 Earnings and Revenue Estimates

Zacks

a year ago

Pitney Bowes (PBI) Beats Q4 Earnings and Revenue Estimates

Profound Medical (PROF) Soars 9.4%: Is Further Upside Left in the Stock?

Zacks

a year ago

Profound Medical (PROF) Soars 9.4%: Is Further Upside Left in the Stock?

GlobeNewswire

a year ago

Cronos’ Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1

EV Roundup: STLA Unveils Electrified Platform, FSR Faces NHTSA Scrutiny & More

Zacks

a year ago

EV Roundup: STLA Unveils Electrified Platform, FSR Faces NHTSA Scrutiny & More

Gogoro to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7th at 7 a.m. Eastern Time

PR Newswire

a year ago

Gogoro to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7th at 7 a.m. Eastern Time

SunOpta (STKL) Stock Dips While Market Gains: Key Facts

Zacks

a year ago

SunOpta (STKL) Stock Dips While Market Gains: Key Facts

Business Wire

a year ago

Mitek Announces Extension of Nasdaq Stay and Hearing Date

Modivcare Appoints New Chief Commercial Officer and Chief Strategy and Innovation Officer

Business Wire

a year ago

Modivcare Appoints New Chief Commercial Officer and Chief Strategy and Innovation Officer

Q3 Rundown: Darden (NYSE:DRI) Vs Other Sit-Down Dining Stocks

StockStory

a year ago

Q3 Rundown: Darden (NYSE:DRI) Vs Other Sit-Down Dining Stocks

Business Wire

a year ago

BlackRock Closed-End Funds have Repurchased approximately $1.3 Billion of Shares since the Share Repurchase Program’s Inception

ID R&D Introduces Voice Clone Detection for Protection Against Gen AI-based Identity Fraud

Business Wire

a year ago

ID R&D Introduces Voice Clone Detection for Protection Against Gen AI-based Identity Fraud

AAM Showcases Next-Gen Electric Drive Solutions at CES

PR Newswire

a year ago

AAM Showcases Next-Gen Electric Drive Solutions at CES

February Risk Alert: 3 Stocks to Unload Now to Protect Your Portfolio

InvestorPlace

a year ago

February Risk Alert: 3 Stocks to Unload Now to Protect Your Portfolio

Why Shares in Trimble Soared in December

Motley Fool

a year ago

Why Shares in Trimble Soared in December

Hain Celestial Rings NASDAQ Closing Bell

CNW Group

a year ago

Hain Celestial Rings NASDAQ Closing Bell

Corcept (CORT) Surges 5.1%: Is This an Indication of Further Gains?

Zacks

a year ago

Corcept (CORT) Surges 5.1%: Is This an Indication of Further Gains?

4 Top Stocks to Buy From a Promising Security and Safety Services Industry

Zacks

a year ago

4 Top Stocks to Buy From a Promising Security and Safety Services Industry

Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference

At US$96.65, Is It Time To Put John Bean Technologies Corporation (NYSE:JBT) On Your Watch List?

Simply Wall St.

a year ago

At US$96.65, Is It Time To Put John Bean Technologies Corporation (NYSE:JBT) On Your Watch List?

Business Wire

a year ago

Olo to Present at the ICR Conference

Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference

Farmland Partners Announces Change to its Board of Directors

Business Wire

a year ago

Farmland Partners Announces Change to its Board of Directors

Should Arko Corp. (NASDAQ:ARKO) Focus On Improving This Fundamental Metric?

Simply Wall St.

a year ago

Should Arko Corp. (NASDAQ:ARKO) Focus On Improving This Fundamental Metric?

Gearing Up for Gains: 3 Top Auto Part Stocks to Buy for 2024

InvestorPlace

a year ago

Gearing Up for Gains: 3 Top Auto Part Stocks to Buy for 2024

ECARX and Black Sesame Technologies Strengthen Partnership to Develop Intelligent Driving Ecosystem

GlobeNewswire

a year ago

ECARX and Black Sesame Technologies Strengthen Partnership to Develop Intelligent Driving Ecosystem

Implied Volatility Surging for Everi Holdings (EVRI) Stock Options

Zacks

a year ago

Implied Volatility Surging for Everi Holdings (EVRI) Stock Options

SunOpta Inc. to Participate in Upcoming Investor Conference

Business Wire

a year ago

SunOpta Inc. to Participate in Upcoming Investor Conference

Companies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In Growth

Simply Wall St.

a year ago

Companies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In Growth

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

PR Newswire

a year ago

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

LSB Industries, Inc.'s (NYSE:LXU) Low P/E No Reason For Excitement

Simply Wall St.

a year ago

LSB Industries, Inc.'s (NYSE:LXU) Low P/E No Reason For Excitement

Smith & Wesson Brands, Inc. (NASDAQ:SWBI) is largely controlled by institutional shareholders who own 52% of the company

Simply Wall St.

a year ago

Smith & Wesson Brands, Inc. (NASDAQ:SWBI) is largely controlled by institutional shareholders who own 52% of the company

Utz Brands to Introduce Long-Term Growth Strategy at 2023 Investor Day

Business Wire

a year ago

Utz Brands to Introduce Long-Term Growth Strategy at 2023 Investor Day

Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders

GlobeNewswire

a year ago

Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders

Business Wire

a year ago

Waffle House Partners with Olo to Lead First Brand-Wide Digital Investment

Rent-A-Center Opens Store in Brooksville, Florida

Business Wire

a year ago

Rent-A-Center Opens Store in Brooksville, Florida

Olo Inc.'s (NYSE:OLO) 27% Jump Shows Its Popularity With Investors

Simply Wall St.

a year ago

Olo Inc.'s (NYSE:OLO) 27% Jump Shows Its Popularity With Investors

Republic Bancorp (NASDAQ:RBCA.A) shareholders have earned a 12% CAGR over the last three years

Simply Wall St.

a year ago

Republic Bancorp (NASDAQ:RBCA.A) shareholders have earned a 12% CAGR over the last three years

Zacks.com featured highlights Axonics, Bel Fuse and Thermon

Zacks

a year ago

Zacks.com featured highlights Axonics, Bel Fuse and Thermon

Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma

GlobeNewswire

a year ago

Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma

Read This Before Considering SunCoke Energy, Inc. (NYSE:SXC) For Its Upcoming US$0.10 Dividend

Simply Wall St.

a year ago

Read This Before Considering SunCoke Energy, Inc. (NYSE:SXC) For Its Upcoming US$0.10 Dividend

Atlanticus Holdings Corp Reports Growth Amidst Economic Headwinds

GuruFocus.com

a year ago

Atlanticus Holdings Corp Reports Growth Amidst Economic Headwinds

Associated Press Finance

a year ago

Lyell Immunopharma: Q3 Earnings Snapshot

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023

GlobeNewswire

a year ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023

Thomson Reuters StreetEvents

a year ago

Q3 2023 Proto Labs Inc Earnings Call

NOW Inc. (NYSE:DNOW) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

NOW Inc. (NYSE:DNOW) Q3 2023 Earnings Call Transcript

Proto Labs (PRLB) Q3 2023 Earnings Call Transcript

Motley Fool

a year ago

Proto Labs (PRLB) Q3 2023 Earnings Call Transcript

Diebold Nixdorf ATM as a Service Transforms Operations for Texas Dow Employees Credit Union

PR Newswire

a year ago

Diebold Nixdorf ATM as a Service Transforms Operations for Texas Dow Employees Credit Union

Share on Social Networks: